U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Ovarian Melanoma

MedGen UID:
1790038
•Concept ID:
C4761026
•
Neoplastic Process

Definition

A melanoma arising from the ovary. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVOvarian Melanoma

Professional guidelines

PubMed

Medicinal Plants in Cancer Treatment: Contribution of Nuclear Factor- Kappa B (NF-kB) Inhibitors.
Das R, Mehta DK, Dhanawat M
Mini Rev Med Chem 2022;22(15):1938-1962. doi: 10.2174/1389557522666220307170126. PMID: 35260052
Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment.
Maroufi NF, Vahedian V, Hemati S, Rashidi MR, Akbarzadeh M, Zahedi M, Pouremamali F, Isazadeh A, Taefehshokr S, Hajazimian S, Seraji N, Nouri M
Pathol Res Pract 2020 May;216(5):152919. Epub 2020 Mar 9 doi: 10.1016/j.prp.2020.152919. PMID: 32171553
SEOM clinical guideline for secondary prevention (2019).
Santaballa A, Pinto Á, Balanyà RP, Ramírez Merino N, Martín IR, Grau SS, Fombella JPB, Cano JM, González CH, Bayo J
Clin Transl Oncol 2020 Feb;22(2):187-192. Epub 2020 Jan 31 doi: 10.1007/s12094-020-02302-0. PMID: 32006339

Recent clinical studies

Etiology

Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s).
Yano M, Nasu K, Yasuda M, Katoh T, Kagabu M, Kobara H, Matsuura M, Tokuyama O, Yamawaki T, Wakahashi S, Noguchi T, Mizuno K, Shitsukawa K, Onohara Y, Nakabori T, Miyasaka A, Nakao T, Matsunaga T, Kunimi Y, Sakurai M, Uchiyama A, Itoh R, Ohike N, Hirakawa T, Watanabe T, Nishino K, Motohashi T, Ito K
Melanoma Res 2022 Jun 1;32(3):150-158. Epub 2022 Mar 29 doi: 10.1097/CMR.0000000000000811. PMID: 35377861
In Defense of Progesterone: A Review of the Literature.
Lieberman A, Curtis L
Altern Ther Health Med 2017 Nov;23(6):24-32. PMID: 29055286
Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y, Ye L, Tan Y, Sun P, Ji K, Jiang WG
Anticancer Res 2014 Mar;34(3):1417-26. PMID: 24596389
Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003.
Du XL, Lin CC, Johnson NJ, Altekruse S
Cancer 2011 Jul 15;117(14):3242-51. Epub 2011 Jan 24 doi: 10.1002/cncr.25854. PMID: 21264829Free PMC Article
Primary ovarian melanoma arising in a dermoid stage IIIc: long-term disease-free survival with aggressive surgery and platinum therapy.
Carlson JA Jr, Wheeler JE
Gynecol Oncol 1993 Mar;48(3):397-401. doi: 10.1006/gyno.1993.1069. PMID: 8462906

Diagnosis

Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s).
Yano M, Nasu K, Yasuda M, Katoh T, Kagabu M, Kobara H, Matsuura M, Tokuyama O, Yamawaki T, Wakahashi S, Noguchi T, Mizuno K, Shitsukawa K, Onohara Y, Nakabori T, Miyasaka A, Nakao T, Matsunaga T, Kunimi Y, Sakurai M, Uchiyama A, Itoh R, Ohike N, Hirakawa T, Watanabe T, Nishino K, Motohashi T, Ito K
Melanoma Res 2022 Jun 1;32(3):150-158. Epub 2022 Mar 29 doi: 10.1097/CMR.0000000000000811. PMID: 35377861
Primary Ovarian Melanoma Arising From a Mature Teratoma With Melanoma In Situ Present in the Ciliated Columnar and Squamous Epithelium in a Patient With Synchronous Skin Basal Cell Carcinoma.
Lai J, Garvey KY, Li P, Azevedo RA
Int J Gynecol Pathol 2021 Jul 1;40(4):383-390. doi: 10.1097/PGP.0000000000000727. PMID: 33560745
SEOM clinical guideline for secondary prevention (2019).
Santaballa A, Pinto Á, Balanyà RP, Ramírez Merino N, Martín IR, Grau SS, Fombella JPB, Cano JM, González CH, Bayo J
Clin Transl Oncol 2020 Feb;22(2):187-192. Epub 2020 Jan 31 doi: 10.1007/s12094-020-02302-0. PMID: 32006339
KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.
Stewart ML, Tamayo P, Wilson AJ, Wang S, Chang YM, Kim JW, Khabele D, Shamji AF, Schreiber SL
Cancer Res 2015 Jul 15;75(14):2897-906. Epub 2015 May 12 doi: 10.1158/0008-5472.CAN-14-2860. PMID: 25968887Free PMC Article
Malignant ovarian melanoma with extensive pelvic and peritoneal metastasis: a case report and literature review.
Gao R, Liu NF, Sheng XG
Chin J Cancer 2010 Apr;29(4):460-2. doi: 10.5732/cjc.009.10479. PMID: 20346227

Therapy

Organ Biodistribution of Radiolabelled γδ T Cells Following Liposomal Alendronate Administration in Different Mouse Tumour Models.
Wang JT, Hodgins NO, Al-Jamal WT, Maher J, Sosabowski JK, Al-Jamal KT
Nanotheranostics 2020;4(2):71-82. Epub 2020 Feb 6 doi: 10.7150/ntno.32876. PMID: 32190534Free PMC Article
SEOM clinical guideline for secondary prevention (2019).
Santaballa A, Pinto Á, Balanyà RP, Ramírez Merino N, Martín IR, Grau SS, Fombella JPB, Cano JM, González CH, Bayo J
Clin Transl Oncol 2020 Feb;22(2):187-192. Epub 2020 Jan 31 doi: 10.1007/s12094-020-02302-0. PMID: 32006339
In Defense of Progesterone: A Review of the Literature.
Lieberman A, Curtis L
Altern Ther Health Med 2017 Nov;23(6):24-32. PMID: 29055286
KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.
Stewart ML, Tamayo P, Wilson AJ, Wang S, Chang YM, Kim JW, Khabele D, Shamji AF, Schreiber SL
Cancer Res 2015 Jul 15;75(14):2897-906. Epub 2015 May 12 doi: 10.1158/0008-5472.CAN-14-2860. PMID: 25968887Free PMC Article
Malignant ovarian melanoma with extensive pelvic and peritoneal metastasis: a case report and literature review.
Gao R, Liu NF, Sheng XG
Chin J Cancer 2010 Apr;29(4):460-2. doi: 10.5732/cjc.009.10479. PMID: 20346227

Prognosis

Clinicopathological features and programmed death-ligand 1 immunohistochemical expression in a multicenter cohort of uterine and ovarian melanomas: a retrospective study in Japan (KCOG-G1701s).
Yano M, Nasu K, Yasuda M, Katoh T, Kagabu M, Kobara H, Matsuura M, Tokuyama O, Yamawaki T, Wakahashi S, Noguchi T, Mizuno K, Shitsukawa K, Onohara Y, Nakabori T, Miyasaka A, Nakao T, Matsunaga T, Kunimi Y, Sakurai M, Uchiyama A, Itoh R, Ohike N, Hirakawa T, Watanabe T, Nishino K, Motohashi T, Ito K
Melanoma Res 2022 Jun 1;32(3):150-158. Epub 2022 Mar 29 doi: 10.1097/CMR.0000000000000811. PMID: 35377861
Primary Ovarian Melanoma Arising From a Mature Teratoma With Melanoma In Situ Present in the Ciliated Columnar and Squamous Epithelium in a Patient With Synchronous Skin Basal Cell Carcinoma.
Lai J, Garvey KY, Li P, Azevedo RA
Int J Gynecol Pathol 2021 Jul 1;40(4):383-390. doi: 10.1097/PGP.0000000000000727. PMID: 33560745
Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic.
Apostolatos AH, Apostolatos CA, Ratnayake WS, Neuger A, Sansil S, Bourgeois M, Acevedo-Duncan M
Anticancer Drugs 2019 Jan;30(1):65-71. doi: 10.1097/CAD.0000000000000694. PMID: 30204596Free PMC Article
KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.
Stewart ML, Tamayo P, Wilson AJ, Wang S, Chang YM, Kim JW, Khabele D, Shamji AF, Schreiber SL
Cancer Res 2015 Jul 15;75(14):2897-906. Epub 2015 May 12 doi: 10.1158/0008-5472.CAN-14-2860. PMID: 25968887Free PMC Article
Metastatic malignant ovarian melanoma--a case report.
Berisavac M, Kotlica BK, Pilić I, Atanacković J
Vojnosanit Pregl 2013 Feb;70(2):229-32. doi: 10.2298/vsp110719030b. PMID: 23607194

Clinical prediction guides

Organ Biodistribution of Radiolabelled γδ T Cells Following Liposomal Alendronate Administration in Different Mouse Tumour Models.
Wang JT, Hodgins NO, Al-Jamal WT, Maher J, Sosabowski JK, Al-Jamal KT
Nanotheranostics 2020;4(2):71-82. Epub 2020 Feb 6 doi: 10.7150/ntno.32876. PMID: 32190534Free PMC Article
Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Alam MS, Lee DU
Arch Pharm Res 2016 Feb;39(2):191-201. Epub 2015 Dec 23 doi: 10.1007/s12272-015-0699-z. PMID: 26694484
Loss of SMARCA4 Expression Is Both Sensitive and Specific for the Diagnosis of Small Cell Carcinoma of Ovary, Hypercalcemic Type.
Conlon N, Silva A, Guerra E, Jelinic P, Schlappe BA, Olvera N, Mueller JJ, Tornos C, Jungbluth AA, Young RH, Oliva E, Levine D, Soslow RA
Am J Surg Pathol 2016 Mar;40(3):395-403. doi: 10.1097/PAS.0000000000000558. PMID: 26645725Free PMC Article
KRAS Genomic Status Predicts the Sensitivity of Ovarian Cancer Cells to Decitabine.
Stewart ML, Tamayo P, Wilson AJ, Wang S, Chang YM, Kim JW, Khabele D, Shamji AF, Schreiber SL
Cancer Res 2015 Jul 15;75(14):2897-906. Epub 2015 May 12 doi: 10.1158/0008-5472.CAN-14-2860. PMID: 25968887Free PMC Article
Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells.
Zhang Y, Ye L, Tan Y, Sun P, Ji K, Jiang WG
Anticancer Res 2014 Mar;34(3):1417-26. PMID: 24596389

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...